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Abstract
Low oxygen tensions experienced in various pathological and physiological conditions are a major
stimulus for angiogenesis. Hypoxic conditions play a critical role in regulating cellular behaviour
including migration, proliferation and differentiation. This study introduces the use of a
microfluidic device that allows for the control of oxygen tension for the study of different three-
dimensional (3D) cell cultures for various applications. The device has a central 3D gel region
acting as an external cellular matrix, flanked by media channels. On each side, there is a peripheral
gas channel through which suitable gas mixtures are supplied to establish a uniform oxygen
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concentration or gradient within the device. The effects of various parameters, such as gas and
media flow rates, device thickness, and diffusion coefficients of oxygen were examined using
numerical simulations to determine the characteristics of the microfluidic device. A polycarbonate
(PC) film with a low oxygen diffusion coefficient was embedded in the device in proximity above
the channels to prevent oxygen diffusion from the incubator environment into the
Polydimethylsiloxane (PDMS) device. The oxygen tension in the device was then validated
experimentally using a ruthenium-coated (Ru-coated) oxygen-sensing glass cover slip which
confirmed the establishment of low uniform oxygen tensions (< 3%) or an oxygen gradient across
the gel region. To demonstrate the utility of the microfluidic device for cellular experiments under
hypoxic conditions, migratory studies of MDA-MB-231 human breast cancer cells were
performed. The microfluidic device allowed for imaging cellular migration with high-resolution,
exhibiting an enhanced migration in hypoxia in comparison to normoxia. This microfluidic device
presents itself as a promising platform for the investigation of cellular behaviour in a 3D gel
scaffold under varying hypoxic conditions.
Introduction
Oxygen tension is one of the most important factors influencing cell viability, migration,
proliferation and differentiation. For instance, stem cells reside in a hypoxic niche, which
regulates their cellular fate.1 Hypoxia promotes proliferation of mesenchymal stem cells,
while restraining their differentiation. It also enhances proliferation and differentiation of
neural stem cells, while reducing cell death.2, 3 In addition, hypoxia is a critical factor of the
tumor microenvironment, with tumors exhibiting increased resistance to radiation therapy
and certain anticancer drugs4, 5 and enhanced metastasis of tumor cells by acute hypoxia.6
These changes due to hypoxia are regulated by various proteins and their signalling
processes, such as hypoxia-inducible factor-1 (HIF-1) and vascular endothelial growth factor
(VEGF).7
Conventional gas variable incubators are most commonly used to study the effects of
oxygen tensions on cell behaviours. These incubators create the desired oxygen environment
by mixing oxygen, nitrogen and carbon dioxide in a predefined ratio. However, these
systems do not allow the generation of oxygen gradients and are limited by the long times
required for equilibrating the gas concentration.8 Several groups developed platforms with
gas microchannels attached to a cell culture well with a thin gas-permeable
Polydimethylsiloxane (PDMS) membrane to generate a hypoxic environment.9, 10 For
example, Oppegard et al.9 developed a device to control oxygen tension temporally (in
minutes) and spatially (in millimetres) in a well plate commonly used for cell cultures.
However, these devices are limited to two-dimensional cell culture studies. On the other
hand, microfluidic systems are versatile tools to study cell behaviours with three-
dimensional (3D) and real-time imaging at high-resolution.11, 12 Due to the high level of
control over the physical and chemical environment, these devices constitute the well-suited
platform for the study of cell behaviour under the influence of various stimuli. These devices
enable studies of migratory and proliferative behaviours of various cell lines when exposed
to gradients of growth factors,13, 14 temperature15, interstitial flow16, and interaction with
multiple cell types17–20. Many microfluidic devices have also been reported to study the
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effects of oxygen tension on cells or oxygen consumption by cells.21–31 The designs
commonly combine a media chamber, a gas-permeable membrane, channels for gas or
oxygen scavenging reagents, and covers of PDMS or glass in order to create a uniform low
oxygen tension.25 Furthermore, oxygen gradients with an arbitrary profile were generated in
microfluidic devices by mixing oxygen and nitrogen in gas channels dividing into multiple
capillaries above a thin PDMS membrane.22, 24, 28, 30 However, such microfluidic devices
with several layers are complicated to fabricate, and there are difficulties in the accurate
control of gas flow rates. Chen et al.21 proposed a single-layer PDMS microfluidic device to
generate oxygen gradients with the aid of spatially confined chemical reactions: oxygen
scavenging/generating chemicals flow through two chemical reaction channels, which
sandwiches a cell culture channel. But the microfluidic device utilized potentially cytotoxic
chemicals, and the oxygen gradients created were nonlinear.
In this paper, we introduce a simple microfluidic device that allows the generation of low
oxygen environments or an oxygen gradient for the study of cells in a 3D environment,
using the flow of predefined harmless gas mixtures through channels in the device.
Minimizing oxygen diffusion from the top surface of the microfluidic device is found to be
essential for maintaining low oxygen tensions. The steady and transient oxygen tension in
the device is numerically simulated under various conditions of media and gas flow rates.
The oxygen tension in the microfluidic device is then correlated to the changes in
fluorescent intensities of a Ru-coated oxygen-sensing glass cover slip bonded to the
microfluidic channels. Finally, we demonstrate the utility of our novel device for studying
the effect of hypoxic conditions on the migration characteristics of human breast cancer cells
(MDA-MB-231).
Material and Methods
Device Design and Fabrication
Figure 1(a) represents the microfluidic device design and configuration. The device consists
of a central channel of 1.3 mm width, into which a 3D extracellular matrix (ECM) such as
collagen gel is injected. Flanking media channels of 500 μm width open out into a combined
outlet port to avoid pressure differences across the gel region. Cells can be seeded in either
the central channel or in the media channels, depending on the application of interest.
Suitable gas mixtures are then infused into the other two peripheral channels of 500 μm
width to establish an oxygen tension of interest or an oxygen gradient across the cell culture
region. All channels have a height of 150 μm; the partitions between media and gas channels
on both sides are set at 150 μm so as to ensure structural stability of the wall and allow for
oxygen diffusion between the gas and media channels. The channel height allows
observation of 3D cellular migration.
Fabrication procedure is depicted in a schematic diagram in Fig. 1(b). The microfluidic
device was fabricated by first transferring the design to a 2 mm layer of PDMS by soft
lithography (Step 1 in Fig. 1(b)). The PDMS (Silgard 184, Dow Chemical, MI, USA) was
mixed at a 10:1 ratio of base:curing agent, poured over the silicon master, and incubated at
80 °C for at least 2 hrs. The cured PDMS layer was peeled off the silicon master, trimmed
and placed on a petri dish (60 mm in diameter) with its patterned side facing the bottom. A
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0.5 mm-thick polycarbonate (PC) film,32, 33 which has a lower oxygen diffusion coefficient
of 8.0×10−12 m2/s than that of PDMS, was cut into a circular shape with a diameter of 35
mm. 3 mm port holes were punched at the locations of media, gas and gel ports, and
positioned with the port holes on top of the corresponding ports on the solid PDMS layer.
Subsequently, fresh PDMS was poured into the petri dish over the first PDMS layer to
sandwich the PC film in the device (Step 2 in Fig. 1(b)). The final thickness of the
microfluidic device was approximately 6 mm. The petri dish containing the device was
placed in an oven at 80 °C overnight. The cured PDMS device was cut out from the petri
dish and punched to form inlets and outlets of 2 mm in diameter for the infusion of media
and gas, and 1 mm in diameter for the infusion of gel. Finally, the patterned side of the
device and a glass cover slip were plasma treated (PDC-001, Harrick, CA, USA) prior to
bonding (Step 3 in Fig. 1(b)).
Numerical Simulation of Oxygen Tensions in the Microfluidic Device
Numerical simulations were performed to investigate the oxygen tension in the device upon
changing various parameters such as media and gas flow rates, device thickness, and effect
of the PC film in the microfluidic device. The computational model of a 6-mm-thick
microfluidic device, within which a 0.5 mm film is embedded at the 2 mm mark, was
constructed for the parameter studies (Fig. 1(a)).
The media and gas flows through the individual channels were simulated by solving the
Navier-Stokes equations and the equation of continuity. Both steady and transient oxygen
tensions inside the device were calculated by solving the convection-diffusion equation.
Simulations were performed by employing commercial finite element software (COMSOL
Multiphysics 3.5a, COMSOL, MA, USA). The computational grid consisted of 120,000 –
140,000 tetrahedral elements. Media containing 21% oxygen was supplied from the two
inlets, merging prior to reaching the single outlet port (Figs. 1(a) and (c)). Gas at 0% oxygen
was supplied to both gas channels through the gas ports in order to establish a uniform
oxygen tension. In another simulation study, (1–10% oxygen was supplied to the left-hand
side’) gas channel, and 21% oxygen to the right-hand side in order to create an oxygen
gradient. Zero pressure and convection flux conditions were set at media and gas outlets,
and a no-slip condition was applied on the channel wall for the fluid flow analysis. The
parameter values used for density, viscosity, and diffusivity of oxygen in media27, 28, 30,
gel34–36, gas, and PDMS26, 37, 38 are summarized in Table 1. In addition, diffusivity in the
embedded film, Dfilm, was assumed in a range of 2.0×10−9 m2/s to 2.0×10−12 m2/s, which
corresponds to conditions in which the film is between two and 2,000 times less gas-
permeable than PDMS, respectively. The Péclet number, the ratio of advection to diffusion,
characterizes transport in the fluid flow:
(1)
where U is the average flow velocity in a channel, and w is the channel width of 500 μm. An
increase of the value of Pe corresponds to an increased flow velocity, resulting in stronger
convective transfer rates, relative to diffusion. In the simulations performed, the Péclet
numbers of media and gas flows, Pem and Peg, were varied as 0, 1, 10, 100, and 1,000,
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respectively, to optimize the media and gas flow rates for a desirable oxygen tension during
cell culture (see Table 1).
Validation of Oxygen Tension
To experimentally validate the simulated oxygen tensions in the device, a sample of
commercially available oxygen-sensing glass cover slip coated with Ru complex dye
(FOXY-SGS, Ocean Optics, FL, USA)9 was bonded to the bottom surface of the PDMS
microfluidic device mold as previously described. For microscopic imaging, a digital CCD
camera (C4742-95-12ER, Hamamatsu Photonics, Japan) connected to an inverted
microscope (ECLIPSE TE300, Nikon, Japan) was employed. The oxygen-sensing glass
cover slip was excited with green laser (λex = 540–580 nm) and the fluorescence (λem = 595
nm) was recorded with a 4x magnification objective. Exposure time for brightness field and
fluorescence imaging was set at 2 ms and 800 ms, respectively. The microscope image size
was 1,344×1,022 pixels (2.18 mm × 1.66 mm).
The procedures of the validation experiment are summarized in Table 2. Since collagen type
I gel was difficult to stabilize on the oxygen-sensing cover slip, leaking to the media
channels easily, it was replaced by water in the validation experiment. Air was bubbled
through water overnight to become saturated with 21% oxygen tension; this saturated water
was added into the media channels and the gel region of the microfluidic device. The two
inlets and one outlet of the media channels were connected to a reservoir, containing water
treated in the same manner, and a syringe pump (EW-74901-00, Cole-Parmer, IL, USA),
respectively (Fig. 1(c)). Water was withdrawn at a flow rate corresponding to Pem = 10
(10.8 μl/h for each media channel), while blocking the gel ports so as not to cause water
flow in the gel region and to prevent evaporation during the experiment. Humidified gas
mixture containing 21% oxygen, 5% carbon dioxide and 74% nitrogen (Airgas East Inc.,
MA, USA) was supplied to both gas channels at the flow rate of Peg = 100 (18 ml/min) to
calibrate the device at 21% oxygen. Fluorescence images of the gel region were captured
after 30 min of thermal and convective equilibrium (procedure 1 in Table 2). Then, the gas
mixture was switched to the one containing 0% oxygen, 5% carbon dioxide and 95%
nitrogen (Airgas East Inc., MA, USA) at the same flow rate to establish a low uniform
oxygen tension in the device. The 0% oxygen gas mixture was humidified using a solution
containing 10 wt% sodium sulfite (Na2SO3) to remove any dissolved oxygen. Fluorescence
images were recorded every five min for the first 30 min, followed by every 30 min for three
hrs, and six and 12 hrs after changing the gas supply (procedure 2 in Table 2). After that, the
gas mixture on the right-hand side was switched to one containing 21% oxygen again to
generate an oxygen gradient, and the fluorescence images were taken in the same manner for
12 hrs (procedure 3 in Table 2). Finally, the water in the media channels and the gel region
was substituted with 10 wt% Na2SO3 solution, and gas flow with the same 0% oxygen gas
was supplied through both gas channels without any media flow (Pem = 0). After allowing
sufficient time for thermal and diffusive equilibrium and chemical reaction of scavenging
oxygen (> 30 min), a fluorescence image was taken for the calibration of 0% oxygen tension
(procedure 4 in Table 2).
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The fluorescence intensity in each image was quantified using image processing software
(ImageJ, NIH, MD, USA). Three fluorescence intensity profiles across the media channels
and gel region were obtained by setting three rectangular regions of interest (ROI) of
1,276×80 pixels (2 mm × 0.13 mm). Each ROI was divided into small sections of 0.1 mm ×
0.13 mm, and the space-averaged fluorescence intensity in each section was obtained. Then,
the fluorescence intensity in each condition was converted to an oxygen tension based on the
Stern-Volmer equation:21
(2)
where I and I0 are the fluorescence intensities in oxic and anoxic atmospheres, respectively.
The quenching constant, Kq, is defined as follows:
(3)
where I100 is the fluorescence intensity in 100% oxygen tension. For the calibration, the
fluorescence intensities, I21 and I0, in 21% and 0% oxygen tension conditions measured
before and after the sequential experiments, respectively, were used. In this case, the
quenching constant, Kq, can be described by changing Eqs. (2) and (3):
(4)
where [O2]air is 21%. The validation experiment was performed three times, using three
microfluidic devices, to check the reproducibility.
Cell Migration Study under Hypoxia
The feasibility of the microfluidic device for cellular experiments was examined by
monitoring the migration of GFP-labelled MDA-MB-231 human breast cancer cell line
(generously provided by Prof. D. Lauffenburger, MIT) under normoxia and hypoxia. The
MDA-MB-231 cells were passaged in standard Dulbecco’s Modified Eagle Medium
(DMEM) (Invitrogen, CA, USA) supplemented with 10% fetal bovine serum (FBS)
(Invitrogen, CA, USA) and cultured in a humidified incubator at 5% CO2 and 37 °C. Cells
were collected by trypsinization and mixed into 1.5 mg/ml collagen type I gel to a final cell
density of 0.5 million cells/ml. Collagen gel solution was introduced into the gel region of
the microfluidic device and polymerized in an incubator for 45 min prior to adding
DMEM/FBS media containing 50 ng/ml EGF (PeproTech, NJ, USA). After 24 hrs of
culture, the microfluidic device was set on the stage of a time-lapse imaging system,
equipped with an inverted microscope (Axiovert 200, Carl Zeiss MicroImaging(2-8) GmbH,
Germany) and digital image processing software (AxioVision, Carl Zeiss MicroImaging
GmbH, Germany), inside an environmental chamber to maintain a humidified atmosphere of
5% CO2 and 37 °C. The following procedures of the cellular experiment are summarized in
Table 2. A gas mixture containing 21% oxygen, 5% carbon dioxide and 74% nitrogen was
supplied at a flow rate corresponding to Peg = 100 through each gas channels to create a
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normoxic condition. No media flow was applied in this study. After thermal equilibrium of
the device (> 30 min), both bright field and fluorescence images were taken at 10x
magnification every 10 min for > 8 hrs (procedure A in Table 2). Hypoxia was then
generated by switching the gas mixture from 21% oxygen gas mixture to 0% oxygen gas
mixture through both gas channels. Microscope images were taken every 10 min for > 8 hrs
to monitor cell migration (procedure B in Table 2).
Cancer cell migration > 2 hrs after supplying each gas mixture in the fluorescence
microscope images was tracked for six hrs. The Imaris software (Bitplane, CT, USA) was
used to analyze net cell displacement (distance between initial and final cell positions), total
path length (total trajectory length obtained by summing all trajectory segments) and their
ratio (persistence) as defined previously.39 The results of 35 randomly selected cells were
averaged in each condition, and three sets of the data with three devices were used to
evaluate the significant differences between cell migration under normoxia and hypoxia by a
Student’s t-test. The differences were considered significant at P < 0.05. Tumor cells were
fixed with 4% Paraformaldhyde, permeabilized with 0.1% Triton-X and stained for DAPI
(Invitrogen, CA, USA) and mouse anti-human HIF-1α (clone H1alpha67, Abcam, MA,
USA) detected with a secondary Alexa568 anti-mouse antibody (Invitrogen, CA, USA). To
quantify expression of HIF-1α, we used ImageJ and measured the mean fluorescent intensity
per cell in the nucleus for at least 10 cells per condition using the method described in the
reference.40
Cell viability was checked after > 8 hrs culture inside the device under normoxia/hypoxia
using LIVE/DEAD Cell Imaging Kit (488/570, Molecular Probes, Life Technologies Corp.,
CA, USA).
Results and Discussion
Characteristics of Oxygen Tension in the Microfluidic Device
Oxygen distribution inside the microfluidic device was simulated by solving the governing
equations for both steady and transient oxygen tensions. The effects of media and gas flow
rates on oxygen concentration were examined.
The oxygen tension at the centre of the gel region on the glass cover slip, (x, y, z) = (0 m,
1.975×10−3 m, 1×10−6 m) (see Fig. 1(a) for location of xyz coordinate axes) in the
microfluidic device with a film of Dfilm = 2.0×10−12 m2/s was obtained from each
computational result. Figures 2(a) summarizes the variation of the oxygen tension with a
combination of Péclet numbers for media and gas flow. Oxygen tension increased with
increasing media flow, Pem, since the medium is convected downstream before it has a
chance to equilibrate with gases diffusing from the gas channels. On the other hand, gas
flow, Peg, exerts little effect on oxygen tension, at least the range tested. The combination of
the media and gas flow rate at (Pem, Peg) = (10, 100) was found to be sufficient to achieve
~2% oxygen tensions, and was used for all further simulations. The oxygen tension at the
same location in the microfluidic device without the film is represented in ESI (Fig. S1). The
efficiency of the film is evident in a comparison of Figs. 2(a) and S1. Without the film, the
lowest oxygen tension attainable is 6.5%.
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Figure 2(b) shows the representative computational results of oxygen tension on the glass
cover slip of the microfluidic device with/without the film at (Pem, Peg) = (10, 100) for a
hypoxic reasonably uniform oxygen tension or a gradient of oxygen tension. Upon
appropriate combinations of media and gas flow rates, a uniform oxygen tension along the
gel region can be maintained. Contours of oxygen tension in the other conditions are shown
in the ESI (Fig. S2). Oxygen tension profiles along a line across the media channels and gel
region, (y, z) = (1.975×10−3 m, 1×10−6 m), are extracted in Fig. 2(c). In the case of gas flow
through both channels, the microfluidic device with a film gives a more uniform oxygen
tension profile in the gel region than that without the film, showing the significant influence
of ambient oxygen diffusion on uniformity of oxygen concentration. The device with an
embedded film also exhibited a more linear gradient of oxygen tension from 15% on right-
hand side to 8% on the left-hand side of gel region, in the gradient case, demonstrating the
beneficial effect of the PC film.
The thickness of the microfluidic device also affected the oxygen tension as oxygen readily
diffuses through the PDMS.41 Oxygen tension in the device without the film decreased with
increasing device thickness (Fig. S3(a)). However, the oxygen tension became independent
of thickness when the device thickness exceeded ~10 mm, and ~5% oxygen concentration
remained at the centre of the gel region, due primarily to oxygen diffusion through the sides
of the device. The oxygen tension in the microfluidic device was further decreased upon
embedding a gas-impermeable film. The efficiency of a film was also investigated by
changing the diffusion coefficient of oxygen through the film. By decreasing the diffusion
coefficient (e.g., by the use of different materials), the steady oxygen concentration can be
further reduced, but only for the values of Dfilm ≥ 2.0×10−11 m2/s, becoming constant
thereafter (Fig. S3(b)).
The transient response to the supply of gas under 0% oxygen conditions was evaluated by
observing the oxygen tension on a glass cover slip at the centre of the gel region in the
device (Fig. 2(d), distributions shown in Fig. S4). In the first 600 s, the two devices with and
without the gas-impermeable film have nearly the same oxygen tension. After that, the
oxygen tension in the device with the film further decreases to less than 5% after 30 min, the
difference being due to oxygen diffusion through the upper surface of the PDMS.
Experimental Validation of Oxygen Tensions in the Microfluidic Device
Oxygen tension was measured based on changes in fluorescence intensity indicated by a Ru
complex coated oxygen-sensing glass cover slip bonded to the bottom of the microfluidic
device. The actual microfluidic device used in the validation experiment had a 7.2 mm
thickness on average, and the PDMS thickness below the PC film was ~2.75 mm.
Figure 3(a) shows microscope images of the microfluidic device. In the bright field image,
the central gel region flanked by media channels and PDMS pillars to contain the gel are
displayed. The corresponding fluorescence image under normoxia at 21% oxygen tension
(21%-21%) was dark though several white dots were observed due to imperfections in the
Ru-coating on the oxygen-sensing glass cover slip. The fluorescence intensity increased
after supplying 0% oxygen gas through both gas channels (0%-0%), indicating oxygen
tension decreased. The oxygen-sensing glass cover slip was first calibrated by using
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intensities with two known oxygen tensions of 21% and 0% (see Fig. 3(a)), and the
quenching constant, Kq, was obtained by Eq. (4). Then, the oxygen tension profile for each
condition was computed using the Stern-Volmer equation of Eq. (2). Figure 3(b) shows a
representative transient change of compensated fluorescence intensity profile or oxygen
tension across the media channels and the gel region in the case of uniform hypoxia,
indicating that > 3 hrs are needed to reach a steady state. Steady oxygen tension profiles in
the cases of a uniform low oxygen tension and an oxygen gradient are summarized in Fig.
3(c). A uniform hypoxia condition with < 3% oxygen tension and an oxygen gradient from
16% on right-hand side to 10% on the left-hand side of gel region was established
experimentally in the microfluidic device.
Compared to the numerical simulation results, the levels of measured oxygen tension were
as low as in the simulation, especially in the case of uniform oxygen tension (Figs. 3(c) and
S5). However, the reduction of oxygen tension achieved took slightly longer than simulated.
The discrepancy between the measurement and the numerical simulation could possibly be
attributed to non-ideal device fabrication and setup errors, resulting in diffusion of
atmospheric oxygen through the gas ports and the flow devices, such as tubing, flowmeters
and humidifier bottles. Perhaps the greatest source of uncertainty is due to the effects of
imperfect bonding of the PC film to PDMS. Uncertainties might also arise in specifying
some of the parameters of the simulation and in the boundary conditions (e.g., the gas
tensions of the incoming fluids) that could account for the observed differences. Finally,
substitution of water for collagen type I gel could lead to small convective flows within the
gel region and affects the oxygen tension, especially in the gradient case.
Cancer Cell Migration under Hypoxia
Hypoxia is known to promote metastasis of a certain tumor cell type, associated with
resistance to anti-cancer drug and radiation therapy, and enhancing their invasive
potential.4–6 Since our microfluidic device is designed for 3D and real-time imaging of cells
in either the gel or media channels under hypoxia, cancer cell behaviour can be observed in
detail. To demonstrate the utility of the microfluidic device, we investigated the migrations
of MDA-MB-231 breast cancer cells under normoxic and hypoxic conditions, by supplying
a 21% and 0% oxygen gas mixture through the two gas channels, respectively, in separate
experiments. The microfluidic device design enabled us to monitor the cell trajectories at
high spatial resolution in real-time (Movie S1). To demonstrate the advantage of our device
to study tumor cell migration in a 3D environment, 3D confocal images of tumor cells
seeded in the device were obtained (Fig. S6). Compared to 2D assays, cell migration in 3D
is more relevant to tumor progression and involves cellular processes such as traction and
proteolysis.42 Furthermore, hypoxic conditions promote over expression of matrix
remodelling enzymes43, therefore 3D ECM migration assays are critical for investigating the
effects of hypoxia in realistic settings. Culture media was not evaporated during the course
of the experiment. Live/dead assay of the cancer cell showed that 89% cells were alive after
> 8 hrs hypoxia (Fig. S7). Hence, cells were viable in the microfluidic device.
Representative migration trajectories of 35 randomly selected cells are shown in Fig. 4(a)
under normoxic and hypoxic conditions. We quantified the net displacement, total path
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length and their ratio (persistence) for all cell trajectories as defined by Fig. 4(b), and found
that these two migration metrics increased upon culture under hypoxic condition, showing
significant differences with the P values of 0.016 and 0.023, respectively (Fig. 4(c)).
Interestingly, hypoxic conditions promoted directional cell migration compared to normoxic
conditions, as indicated by the higher persistence values (see Fig. 4(b)). This increased
invasive behaviour of MDA-MB-231 cancer cells under hypoxia is in agreement with other
reported studies.44–47 Subarsky et al.44 reported that cancer cell invasion was increased due
to hypoxia of ≤ 5% oxygen tension, and Voss et al.45 reported a 1.5 fold increase in the cell
locomotion when the cells were incubated under hypoxic conditions of 1% oxygen tension.
Furthermore, average speed of the cancer cell migration was calculated every hour (Fig.
4(d)), resulting in 1.5-fold increase by hypoxia on average. Our measurements of the
migration speed in the 3D matrix agree well with previous reports under static conditions.39
To confirm that hypoxia associated signalling pathways are activated in our device under
hypoxia, we performed immunostaining against HIF-1α and found an increase of HIF-1α
expression in the cancer cells compared to normoxia (Fig. S8).43,48, 49 A 1.7-fold increase in
nuclear localization of HIF-1α in hypoxia compared to normoxia was detected, while we
also observed a significantly higher increase (5.1-fold) under CoCl2 stimulation (100μM).
This increase in nuclear localization of HIF-1α under hypoxic conditions suggests increased
activation of pathways controlled the HIF-1 transcription factor, which can result in
enhanced tumor invasiveness43, and thus may explain the observed difference in Fig. 6.
The in vivo oxygen tension in breast cancers was measured by Vaupel et al.50 The median
value of the oxygen tension was 30 mmHg (~ 4%), compared to 65 mmHg in normal breast
tissue. Oxygen tension created in cell migration experiment was therefore appropriate to
study the hypoxic effect on cancer cell behaviour. These results demonstrate the potential of
our microfluidic device for the study of cell behaviour under controlled hypoxic conditions.
An interesting direction for future work is the investigation of tumor cell directional
migration under oxygen gradients.
Conclusions
This study reports a novel design of a microfluidic device for the culture of cells in a 3D
hypoxic environment. Various parameters for defining the characteristics of the microfluidic
device were optimised by numerical simulations to achieve a desired level of oxygen
tension. The device was successfully validated, exhibiting a reasonably uniform low oxygen
tension or an oxygen gradient across the gel region. The microfluidic device allowed for
real-time imaging of human breast cancer cell migration in a 3D environment.
Quantification of the cell trajectories demonstrated an enhanced migration of the cells in
hypoxia in comparison to normoxia, further verifying the hypoxic environment generated
within the device. Prospective application of this device lies in the study of other hypoxia-
correlated cellular behaviours, such as proliferation, angiogenesis, and metabolism.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Microfluidic device and experimental setup: (a) The design and configuration of a 6-mm-
thick microfluidic device, within which a 0.5 mm polycarbonate (PC) film is embedded at
the z = 2 mm mark, (b) a schematic of the device fabrication process, and (c) the
experimental setup for hypoxia studies with cell culture.
Funamoto et al. Page 13
Lab Chip. Author manuscript; available in PMC 2014 July 08.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
Results in the numerical simulations of oxygen tension in the microfluidic device with/
without a film of low diffusion coefficient of oxygen (Dfilm = 2.0×10−12 m2/s), supplying
0% oxygen gas to both gas channels (0%-0%) or supplying it to the left-hand side gas
channel, while supplying 21% oxygen gas to the right-hand side (0%-21%): (a) contour map
of oxygen tension at the center of the gel region on a glass cover slip, (x, y, z) = (0 m,
1.975×10−3 m, 1×10−6 m), in the microfluidic device with the film with a combination of
Péclet numbers for media and gas flow in the 0%-0% case, (b) steady oxygen tension on a
crosssection (z = 1.0×10−6 m) and (c) the profile across the middle of the gel region (gray
shaded zone), (y, z) = (1.975×10−3 m, 1×10−6 m) at media and gas flow rates of (Pem, Peg)
= (10, 100), and (d) the transient change of oxygen tension at the center of the gel region.
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Figure 3.
Results in the validation experiment: (a) a set of bright field and fluorescence microscope
images of the microfluidic device in various conditions, and (b) transient oxygen tension
profiles across the gel region (gray shaded zone) after supplying 0% oxygen gas to both gas
channels (0%-0%), and (c) steady oxygen tension profiles 12 hrs after supplying 0% oxygen
gas to both gas channels (0%-0%) or supplying it to the left-hand side gas channels, while
supplying 21% oxygen gas to the right-hand side (0%-21%). Each oxygen tension profile
does not change after six hrs. Error-bars represent standard deviation.
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Figure 4.
Cancer cell migration under normoxia and hypoxia for six hrs: (a) trajectories of 35 cells in
one device, (b) definition of metrics, (c) net displacement, total path length and their ratio
(persistence) of cancer migration obtained with three microfluidic devices, and (d) the
average speed of the migration. Error-bars represent standard deviation.
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